TY  - RPRT
TI  - Technology evaluation: adalimumab, Abbott laboratories.
AU  - Hanns M Lorenz
PY  - 2002
UR  - https://pubmed.ncbi.nlm.nih.gov/12044041/
ID  - 12044041
ER  -